ATP6V0D1 and Parkinson disease: In Parkinson’s disease miR-5701 was reported to modulate mitochondrial-lysosomal cross talk, targeting genes involved in lysosomal biogenesis and mitochondrial quality control (VCP, LAPTMA4A, ATP6V0D1).